WALTER KLEMP V. - 22 Jun 2023 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Role
CEO and President, Director
Signature
/s/ Jonathan P. Foster by Power of Attorney
Issuer symbol
MBRX
Transactions as of
22 Jun 2023
Net transactions value
$0
Form type
4
Filing time
26 Jun 2023, 18:20:18 UTC
Previous filing
22 Jun 2023
Next filing
05 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBRX Stock option (right to buy) Award +400,000 +39% 1,416,691 22 Jun 2023 Common Stock 400,000 $0.6000 Direct F1, F2
transaction MBRX Restricted Stock Units Award +539,375 +38% 1,956,066 22 Jun 2023 Common Stock 539,375 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.
F2 Issued in connection with the reporting person's employment with the Company.Issued in connection with the reporting person's employment with the Company.
F3 Each restricted stock unit represents a contingent right to receive one shares of Company common stock.
F4 The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.